A Double-Blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-Compulsive Disorder
Archives of General Psychiatry
doi 10.1001/archpsyc.57.8.794
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2000
Authors
Publisher
American Medical Association (AMA)